Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events - Additional Information (Detail)

v2.4.0.8
Subsequent Events - Additional Information (Detail) (USD $)
0 Months Ended
Aug. 31, 2014
Sep. 26, 2014
Subsequent Event
Sep. 26, 2014
Subsequent Event
Subsequent Event [Line Items]      
Convertible note financing amount     $ 2,000,000
Convertible note, term   2 years  
Convertible notes, maturity date   Sep. 26, 2016  
Convertible note, interest rate percentage     5.00%
Convertible note, conversion price $ 0.75   $ 1.00
Convertible note, conversion price description   The conversion price is subject to (i) adjustment for stock splits and similar corporate events and (ii) reduction to a price per share that is 10% below the lowest sale price that is below $.9444 per share, for shares of CytoDyn common stock sold in future securities offerings, if any, including sales to AVCP and its designees.  
Percentage reduction to conversion price   10.00%  
Sale price of common stock     $ 0.9444
Warrants to purchase common shares, shares     250,000
Warrants exercise price per share     $ 0.50
Warrants, expiration date   Dec. 31, 2019